Empiric Antibiotics for Dog Bite
Amoxicillin-clavulanate 875/125 mg twice daily is the first-line empiric antibiotic for dog bite wounds. 1
First-Line Treatment
- Amoxicillin-clavulanate is the oral antibiotic of choice for empiric treatment of dog bites, providing comprehensive coverage against the polymicrobial flora typical of these wounds 1
- The standard adult dose is 875/125 mg twice daily or 500/125 mg three times daily, taken at the start of meals to enhance absorption and minimize gastrointestinal side effects 2
- This combination effectively covers Pasteurella multocida (present in ~50% of dog bites), staphylococci, streptococci, and anaerobes 1
- The clavulanate component is critical for addressing beta-lactamase-producing organisms commonly found in animal bite wounds 1
Alternative Regimens for Penicillin Allergy
If the patient has a penicillin allergy, choose from these options:
- Doxycycline 100 mg twice daily - excellent activity against P. multocida and provides good coverage, though some streptococci may be resistant 1
- Moxifloxacin 400 mg daily - can be used as monotherapy with good coverage of both aerobes and anaerobes 1
- Levofloxacin 750 mg daily OR ciprofloxacin 500-750 mg twice daily PLUS metronidazole 500 mg three times daily - the fluoroquinolone covers P. multocida but requires metronidazole for anaerobic coverage 1
Intravenous Options for Severe Infections
For hospitalized patients or severe infections requiring IV therapy:
- Ampicillin-sulbactam 1.5-3.0 g every 6 hours 1
- Piperacillin-tazobactam 3.37 g every 6-8 hours 1
- Ertapenem 1 g daily or other carbapenems 1
- Cefoxitin 1 g every 6-8 hours (second-generation cephalosporin) 1
Note: All IV options miss MRSA coverage; add vancomycin if MRSA is suspected 1
Critical Antibiotics to AVOID
Do not use these antibiotics for dog bites as they lack adequate coverage against P. multocida:
- First-generation cephalosporins (cephalexin, cefazolin, cefadroxil) - consistently ineffective against P. multocida 1, 3
- Clindamycin monotherapy - misses P. multocida despite good activity against staphylococci, streptococci, and anaerobes 1
- Dicloxacillin or oxacillin alone - inadequate P. multocida coverage 1, 3
- Macrolides (erythromycin) - poor activity against P. multocida 1, 3
Essential Wound Management Considerations
Beyond antibiotics, proper wound care is critical:
- Copious irrigation is essential and may significantly reduce infection risk 1
- Do not close infected wounds - this is a fundamental principle 1
- Facial wounds are an exception and may be closed primarily with meticulous wound care, copious irrigation, and preemptive antibiotics 1
- Tetanus prophylaxis should be administered if vaccination is not current within 10 years (Tdap preferred over Td if not previously given) 1
High-Risk Scenarios Requiring Special Attention
- Hand wounds are often more severe than wounds on fleshy body parts and warrant closer monitoring 1
- Pain disproportionate to injury near bone or joint suggests possible periosteal penetration, osteomyelitis, or septic arthritis 1
- Patients with asplenia or liver disease are at higher risk for Capnocytophaga canimorsus bacteremia and sepsis 1
- Complications such as osteomyelitis or septic arthritis require prolonged therapy (4-6 weeks) 1
Clinical Evidence Supporting Amoxicillin-Clavulanate
The recommendation for amoxicillin-clavulanate is supported by both guideline consensus and clinical research demonstrating its effectiveness as monotherapy for moderate dog bite wounds, with over 90% of both gram-negative and gram-positive isolates showing susceptibility 4, 5